Lilly Foundation Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2006
NCT00575835
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Finland: Lilly saatio foundation | Lilly saatio foundation